Leviathan Therapeutics reported raising $250,000 in an initial SEC Form D filing, from an offering of $1 Million
Round Type
Venture
Quick answer
Leviathan Therapeutics raised $250,000 in a funding round, dated July 22, 2022. Leviathan Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Leviathan Therapeutics raise?
- Leviathan Therapeutics raised $250,000 in a funding round on July 22, 2022.
- Where is Leviathan Therapeutics based and how big is it?
- Leviathan Therapeutics is based in Waltham, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Leviathan Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Monteris Medical raised $14M on September 2, 2022.
- Abivax raised $49M (Funding Round) on September 2, 2022.
- Ceres Nanosciences, Inc. raised $5M on September 1, 2022.
- FathomX raised an undisclosed amount (Pre-Series A) on September 1, 2022.
- Bekaert raised an undisclosed amount on September 1, 2022.
- Puna Bio raised $3.7M (Seed) on September 1, 2022.
Who to call at Leviathan Therapeutics, and when
A new round usually means Leviathan Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Leviathan Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Leviathan Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Leviathan Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Leviathan Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Leviathan Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.